Glimibose PM 1mg/500mg/15mg Tablet SR
Marketer
B.J.Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimibose PM 1mg/500mg/15mg Tablet SR
Combiflex SR tablets (1mg/500mg/15mg) effectively manage blood glucose in adults with type 2 diabetes. This triple-action formulation, used alongside diet and exercise, enhances insulin effectiveness, resulting in reduced blood sugar. Dosage and frequency should strictly follow your physician's instructions. Take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose. Overdosage can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or skipped meals elevates hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, increased fracture risk, and respiratory infections. Pre-existing kidney, liver, or heart conditions, pregnancy, or breastfeeding necessitate prior consultation with your doctor, who will assess kidney function before initiating treatment. Limit alcohol consumption to mitigate potential side effects.
Uses of Glimibose PM 1mg/500mg/15mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Glimibose PM 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume the Glimibose PM 1mg/500mg/15mg sustained-release tablet with food.
Common Side effects of Glimibose PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimibose PM 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimibose PM 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Glimibose PM 1mg/500mg/15mg Tablet SR works:
Glimibose PM SR tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, acts triply: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glimibose PM 1mg/500mg/15mg SR tablet use is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimibose PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimibose PM tablets (1mg/500mg/15mg) are likely not suitable for use while breastfeeding. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimibose PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimibose PM 1mg/500mg/15mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Glimibose PM 1mg/500mg/15mg SR tablets cautiously, as dose modification may be necessary. Medical advice is recommended. Glimibose PM 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimibose PM 1mg/500mg/15mg Tablet SR :
Should you forget a Glimibose PM 1mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimibose PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Medication for diabetes |
3,018 People bought this recently